Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients is a research paper published in Scientific Reports (2022). On theSindex it has a DataRank of 0.358. It has been cited 5 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0890
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
Lundbeck Foundation
Grant: R310-2019-167
Lundbeck Foundation
Grant: R278-2018-548
European Research Council
Grant: 668532
“In Vivo Click PET Imaging Agents”: Improving clinical companion diagnostics
Novo Nordisk Fonden
Grant: NNF20OC0062819
European Commission
Grant: 670261
Molecular imaging and targeted therapy of the aggressive phenotype: development of uPAR theranostics for cancer patients
FWCI
0.94
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals